Gelteq Limited Ordinary S... (GELS)
1.97
-0.15 (-7.08%)
At close: Feb 20, 2025, 3:59 PM
2.01
2.03%
After-hours: Feb 20, 2025, 06:47 PM EST
undefined% (undefined)
| Bid | 1.85 |
| Market Cap | 18.59M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.24 |
| PE Ratio (ttm) | -8.21 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 2.16 |
| Volume | 13,415 |
| Avg. Volume (20D) | 525,681 |
| Open | 2.16 |
| Previous Close | 2.12 |
| Day's Range | 1.90 - 2.16 |
| 52-Week Range | 1.42 - 5.50 |
| Beta | undefined |
About GELS
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia....
Sector Healthcare
IPO Date n/a
Employees 7
Stock Exchange NASDAQ
Ticker Symbol GELS
Website https://www.gelteq.com
2 months ago
+91.02%
Gelteq shares are trading higher after the company...
Unlock content with
Pro Subscription